Multiple sclerosis (MS) is a chronic neurodegenerative and autoimmune disease. Motor,
sensory and cognitive deficits in MS are commonly accompanied by psychiatric disorders …

Comorbid conditions commonly affect people with multiple sclerosis (MS). Population-based
studies indicate that people with MS have an increased incidence of ischemic heart disease …

Background: Longitudinal studies of health-related quality of life (HRQoL) in multiple
sclerosis (MS) are limited. Most have examined average changes within the population …

Purpose Resveratrol (Res) is a natural polyphenolic compound found in several plants and
reported as a promising biological molecule with effective anti-fibrosis and anti-inflammatory …

Purpose Vascular comorbidities are prevalent and can contribute to adverse health
outcomes in persons with multiple sclerosis (PwMS). Understanding the association …

Background The prevalence of osteoporosis is reported differently. We designed this
systematic review and meta-analysis to estimate pooled prevalence of osteoporosis and …

Background More research is needed to understand the contribution of comorbidities to MS
symptomatology. Objectives To examine the dose–response relationship between the …

A number of studies have suggested that multiple sclerosis (MS) can be associated with
serious vascular complications, for which pulmonary thromboembolism (PTE) is a potentially …

Background: Comorbidities and poor sleep quality are prevalent among individuals with
multiple sclerosis (MS). Our understanding of the effects of comorbidities on sleep quality in …

Introduction The health-related quality of life (HRQoL) of people with (Pw) multiple sclerosis
(MS) is usually deteriorated. It has been recently suggested that comorbidities may have the …